Recruiting NA INTERVENTIONAL 1-arm
NCT07127172
GB-PRIME: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices (GB-PRIME)
Sponsor: Neuralink Corp
Conditions
Amyotrophic Lateral Sclerosis (ALS) Brain Stem Stroke Cervical Spinal Cord Injury Motor Neuron Disease Quadriplegia Quadriplegia/Tetraplegia Spinal Cord Injury Spinal Cord Injury (Quadraplegia) Tetraplegia/Tetraparesis
Interventions
N1 Implant R1 Robot
Updated 1 time since 2025 Last updated: Aug 11, 2025 Started: Jul 31, 2025 Primary completion: Jan 31, 2028 Completion: Feb 28, 2031
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This NA trial investigates Amyotrophic Lateral Sclerosis (ALS) and Brain Stem Stroke and is currently actively recruiting participants. Neuralink Corp leads this study, which shows 1 recorded version since 2025 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
1 version recorded Recruiting — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Neuralink Corp
- Newcastle-upon-Tyne Hospitals NHS Trust
- University College London Hospitals
Data source: Neuralink Corp
For direct contact, visit the study record on ClinicalTrials.gov .